Released Nov 14, 2014, after the close
10-Q filed Nov 14, 2014, 45 days after period end · 0001437749-14-020858
Q3 2014 · 10-Q
Revenue$1.28M$1.28M +197.5% vs Q3 2013+218.7% vs Q2 2014
Net Income-$51.53K-$51.53K N/M vs Q3 2013N/M vs Q2 2014
EPS Diluted$0.00$0.00 N/M vs Q3 2013N/M vs Q2 2014
Gross Profit$1,039,893+216.5%
Operating Income-$274,620N/M
Operating Cash Flowderived-$346,728N/M
Free Cash Flowderived-$350,580N/M
Margins · derived
Gross margin81.0%+4.9 pt vs Q3 2013
Operating margin-21.4%+156.0 pt vs Q3 2013
Net margin-4.0%+177.3 pt vs Q3 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $1.28M | $431.58K | $409.92K | $574.09K |
| Net Income | -$51.53K | -$782.55K | -$232.61K | -$540.17K |
| EPS Diluted | $0.00 | -$0.01 | $0.00 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Key International Inc · CIK 1019034 · Engraved from SEC EDGAR